Citi lowered the firm’s price target on Clorox to $150 from $155 and keeps a Neutral rating on the shares. The company’s sales recovery post the cyberattack slowed in fiscal Q3, the analyst tells investors in a research note. The firm believes the stock will be more driven by the sales trajectory going forward with re-inflating commodities posing risk to margins in fiscal 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX: